Richter Pharma AG 2022 SR
The report outlines Richter Pharma AG's sustainability strategy and ESG programme for the period up to 2025. Key highlights include the company's commitment to reducing Scope 1 and 2 emissions by 25% and waste by 10% by 2025. In 2022, the company sourced 35% of its total energy from renewable sources. Additionally, Richter Pharma launched investment projects worth over ‐100 million, integrating ESG criteria into its project evaluations and purchasing guidelines.
Company: Richter Pharma AG
Sector: Wholesale & retail
Country: Austria
Year: 2022
Type: SR
Pages: 29
Richter Pharma AG
The report outlines Richter Pharma AG's sustainability strategy and ESG programme for the period up to 2025. Key highlights include the company's commitment to reducing Scope 1 and 2 emissions by 25% and waste by 10% by 2025. In 2022, the company sourced 35% of its total energy from renewable sources. Additionally, Richter Pharma launched investment projects worth over ‐100 million, integrating ESG criteria into its project evaluations and purchasing guidelines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Workplace Fatalities
Employees